INO Earnings INOVIO PHARMACEUTICALS, INC.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | -0.07 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.28 | 2026-05-13 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 0.18 | 2026-03-12 | 10-K |
| FY 2025 | 2025-12-31 | -1.81 | 2026-03-12 | 10-K |
| Q3 2025 | 2025-09-30 | -0.87 | 2025-11-10 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.61 | 2025-08-12 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.51 | 2025-05-13 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -0.56 | 2025-03-18 | 10-K |
| FY 2024 | 2024-12-31 | -3.95 | 2025-03-18 | 10-K |
| Q3 2024 | 2024-09-30 | -0.89 | 2024-11-14 | 10-Q |
| Q2 2024 | 2024-06-30 | -1.19 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.31 | 2024-05-13 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -1.07 | 2024-03-06 | 10-K |
| FY 2023 | 2023-12-31 | -6.09 | 2024-03-06 | 10-K |
| Q3 2023 | 2023-09-30 | -1.52 | 2023-11-09 | 10-Q |
| Q2 2023 | 2023-06-30 | -1.61 | 2023-08-09 | 10-Q |
| Q1 2023 | 2023-03-31 | -1.89 | 2023-05-10 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -2.43 | 2023-03-01 | 10-K |
| FY 2022 | 2022-12-31 | -14.07 | 2023-03-01 | 10-K |
| Q3 2022 | 2022-09-30 | -1.80 | 2022-11-08 | 10-Q |
| Q2 2022 | 2022-06-30 | -5.52 | 2022-08-09 | 10-Q |
| Q1 2022 | 2022-03-31 | -4.32 | 2022-05-10 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -6.05 | 2022-03-01 | 10-K |
| FY 2021 | 2021-12-31 | -17.45 | 2022-03-01 | 10-K |
| Q3 2021 | 2021-09-30 | -3.48 | 2021-11-09 | 10-Q |
| Q2 2021 | 2021-06-30 | -4.68 | 2021-08-09 | 10-Q |
| Q1 2021 | 2021-03-31 | -3.24 | — | — |
| Q4 2020 | 2020-12-31 | -1.68 | 2021-03-01 | 10-K |
| FY 2020 | 2020-12-31 | -12.84 | — | — |
| Q3 2020 | 2020-09-30 | 1.32 | 2020-11-09 | 10-Q |
| Q2 2020 | 2020-06-30 | -9.96 | — | — |
| Q1 2020 | 2020-03-31 | -3.12 | — | — |
| Q4 2019 | 2019-12-31 | -4.56 | 2020-03-12 | 10-K |
| FY 2019 | 2019-12-31 | -14.52 | 2020-03-12 | 10-K |
| Q3 2019 | 2019-09-30 | -3.00 | 2019-11-12 | 10-Q |
| Q2 2019 | 2019-06-30 | -3.60 | 2019-08-08 | 10-Q |
| Q1 2019 | 2019-03-31 | -3.60 | — | — |
| Q4 2018 | 2018-12-31 | -4.08 | 2019-03-12 | 10-K |
| FY 2018 | 2018-12-31 | -12.60 | 2019-03-12 | 10-K |
| Q3 2018 | 2018-09-30 | -3.24 | 2018-11-08 | 10-Q |
| Q2 2018 | 2018-06-30 | -0.96 | 2018-08-07 | 10-Q |
| Q1 2018 | 2018-03-31 | -4.32 | 2018-05-09 | 10-Q |
| Q4 2017 | 2017-12-31 | -2.88 | 2018-03-14 | 10-K |
| FY 2017 | 2017-12-31 | -13.08 | 2018-03-14 | 10-K |
| Q3 2017 | 2017-09-30 | -4.80 | 2017-11-08 | 10-Q |
| Q2 2017 | 2017-06-30 | -1.56 | — | — |
| Q1 2017 | 2017-03-31 | -3.72 | 2017-05-10 | 10-Q |
| Q4 2016 | 2016-12-31 | -4.32 | 2017-03-15 | 10-K |
| FY 2016 | 2016-12-31 | -12.12 | 2017-03-15 | 10-K |
| Q3 2016 | 2016-09-30 | -3.36 | 2016-11-09 | 10-Q |
| Q2 2016 | 2016-06-30 | -3.12 | 2016-08-08 | 10-Q |
| Q1 2016 | 2016-03-31 | -1.32 | 2016-05-09 | 10-Q |
| Q4 2015 | 2015-12-31 | -3.00 | 2016-03-14 | 10-K |
| FY 2015 | 2015-12-31 | -5.28 | 2016-03-14 | 10-K |
| Q3 2015 | 2015-09-30 | 0.84 | 2015-11-09 | 10-Q |
| Q2 2015 | 2015-06-30 | -1.08 | 2015-08-10 | 10-Q |
| Q1 2015 | 2015-03-31 | -2.16 | 2015-05-11 | 10-Q |
| Q4 2014 | 2014-12-31 | -1.44 | 2015-03-16 | 10-K |
| FY 2014 | 2014-12-31 | -7.68 | 2015-03-16 | 10-K |
| Q3 2014 | 2014-09-30 | -1.44 | 2014-11-10 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.